Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Deferred Taxes (2020 - 2024)

Historic Deferred Taxes for Revolution Medicines (RVMD) over the last 4 years, with Q4 2024 value amounting to $762000.0.

  • Revolution Medicines' Deferred Taxes rose 167209.3% to $762000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $928000.0, marking a year-over-year increase of 58082.9%. This contributed to the annual value of $762000.0 for FY2024, which is 8051.15% down from last year.
  • Revolution Medicines' Deferred Taxes amounted to $762000.0 in Q4 2024, which was up 167209.3% from $43000.0 recorded in Q4 2023.
  • Over the past 5 years, Revolution Medicines' Deferred Taxes peaked at $762000.0 during Q4 2024, and registered a low of -$359000.0 during Q4 2020.
  • For the 4-year period, Revolution Medicines' Deferred Taxes averaged around $217166.7, with its median value being $83000.0 (2022).
  • In the last 5 years, Revolution Medicines' Deferred Taxes plummeted by 6504.07% in 2023 and then soared by 167209.3% in 2024.
  • Quarter analysis of 4 years shows Revolution Medicines' Deferred Taxes stood at -$359000.0 in 2020, then skyrocketed by 134.26% to $123000.0 in 2022, then tumbled by 65.04% to $43000.0 in 2023, then skyrocketed by 1672.09% to $762000.0 in 2024.
  • Its Deferred Taxes was $762000.0 in Q4 2024, compared to $43000.0 in Q4 2023 and $123000.0 in Q4 2022.